These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7490001)

  • 1. Economic modeling of treatment in chronic hepatitis B and chronic hepatitis C: promises and limitations.
    Koff RS; Seeff LB
    Hepatology; 1995 Dec; 22(6):1880-2. PubMed ID: 7490001
    [No Abstract]   [Full Text] [Related]  

  • 2. [The cost-benefit of interferon therapy in chronic viral liver diseases].
    Ascione A; De Luca M
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):123-5. PubMed ID: 7542483
    [No Abstract]   [Full Text] [Related]  

  • 3. [Viral hepatitides B and C: medical progress versus economic difficulties ].
    Nau JY
    Rev Med Suisse; 2014 May; 10(432):1220-1. PubMed ID: 24964536
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of chronic hepatitis C: doubts about a cost-effectiveness analysis].
    Bergmann JF
    Gastroenterol Clin Biol; 1997; 21(4):336-8. PubMed ID: 9208001
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cost-effectiveness analysis of the treatment of chronic hepatitis C].
    Joliot E; Vanlemmens C; Kerleau M; Le Gales C; Woronoff-Lemsi MC; Flori YA; Seror V; Hrusovsky S; Monnet E; Bresson-Hadni S; Miguet JP
    Gastroenterol Clin Biol; 1996; 20(11):958-67. PubMed ID: 9119185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon and other therapies for hepatitis B and hepatitis C infections.
    Rothstein KD; Munoz SJ
    Clin Lab Med; 1996 Jun; 16(2):465-91. PubMed ID: 8792083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medico-economic evaluation: aims, methodology, limits].
    Daures JP; Delande G
    Gastroenterol Clin Biol; 2000 Nov; 24(11):1029-31. PubMed ID: 11139670
    [No Abstract]   [Full Text] [Related]  

  • 8. [Detection and examination of carriers of parenteral hepatitis and HIV-infection markers among the young reinforcement: economic expenses for investigations conducted in Moscow military district].
    Mar'in GG; Mel'nichenko PI; Ogarkov PI; Sabilev VI; Ul'ianov VA; Novikov VA
    Voen Med Zh; 2005 Jun; 326(6):40-5. PubMed ID: 16053048
    [No Abstract]   [Full Text] [Related]  

  • 9. [Medico-economic assessment of the therapeutic management of patients with hepatitis C].
    Loubière S; Rotily M; Moatti JP
    Gastroenterol Clin Biol; 2000 Nov; 24(11):1047-51. PubMed ID: 11139674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The treatment of chronic viral hepatitis B/D and acute and chronic viral hepatitis C. The consensus of the German Society for Digestive and Metabolic Diseases].
    Hopf U; Niederau C; Kleber G; Fleig WE
    Z Gastroenterol; 1997 Nov; 35(11):971-86. PubMed ID: 9490556
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interferon-alpha in the treatment of chronic viral hepatitis].
    Melman ML
    Rev Gastroenterol Mex; 1994; 59(2 Suppl):46-8. PubMed ID: 8091094
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy of hepatitis C: cost-effectiveness analysis.
    Koff RS
    Hepatology; 1997 Sep; 26(3 Suppl 1):152S-155S. PubMed ID: 9305681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An economic evaluation of the costs of alpha-interferon treatment of chronic active hepatitis due to hepatitis B or C virus.
    Garcia de Ancos JL; Roberts JA; Dusheiko GM
    J Hepatol; 1990; 11 Suppl 1():S11-8. PubMed ID: 2127784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of viral hepatitis].
    Dhumeaux D
    Servir; 1991; 39(6):304-5. PubMed ID: 1723221
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of chronic viral hepatitis].
    Sperl J
    Vnitr Lek; 1995 Mar; 41(3):182-4. PubMed ID: 7762176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic viral hepatitis: when interferon does not work].
    Costa C; Rizzetto M
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):127-31. PubMed ID: 7542484
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment.
    Teuber G; Dienes HP; Meyer zum Büschenfelde KH; Gerken G
    Hepatogastroenterology; 1995 Apr; 42(2):189-91. PubMed ID: 7672771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of interferon in the treatment of chronic viral hepatitis.
    Gibas AL
    Gastroenterologist; 1993 Jun; 1(2):129-42. PubMed ID: 8049886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How to follow treated and untreated chronic hepatitis B and C].
    Adler M; Golstein P; Botembe N; Bourgeois N
    Rev Med Brux; 1997 Sep; 18(4):183-6. PubMed ID: 9411639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of interferon in chronic active hepatitis C.
    Sallie R
    Med J Aust; 1994 Jul; 161(2):169-70. PubMed ID: 8080533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.